We collected information on HIV testing rates among MSM from 2001

We collected information on HIV testing rates among MSM from 2001 to 2011. Linear regression Lumacaftor in vivo was performed to estimate the change in HIV testing rates over time, with 95% confidence intervals (CIs), using information obtained from the available studies. Spearman’s rank correlation was performed to investigate the relationship between testing rates and the average age of surveyed MSM (P-value < 0.05 represents statistical significance). All analyses were performed in stata 10 (version 10.0, College Station, Texas, USA). We identified 1878 articles using the initial keywords (1872 articles were obtained from eight electronic databases and six relevant articles were

identified from the reference lists of these articles). After screening the titles of the 1878 articles, 1574 articles were excluded because of duplication or because they were unrelated to the topic. The abstracts of the remaining 304 articles were screened, and 97 articles were further excluded because they were not related to the topic. There were 207 articles eligible for full-text screening, of which 152 articles were subsequently excluded (143 articles did not report the level of HIV testing; five were duplicated in the databases;

two reported HIV testing rates among male sex workers, and two did not report the study period). Finally, we identified 55 eligible articles (44 in Chinese and 11 in English) that reported the HIV testing rate among Chinese MSM, EPZ015666 datasheet which in total provided 37 testing rate estimates for individuals who had ever been tested for HIV during 2002–2009 and 29 testing rate estimates for individuals who had been tested in the past 12 months during 2003–2009 (Table 1). The selection process is illustrated in Figure S1. Among the 55 studies, eight studies reported the HIV testing rate in multiple years [25-32]. Eight of the 55 studies

did not report the recruitment method, while 24 studies recruited MSM participants from MSM venues, six recruited from Internet sites, five recruited from VCT clinics and one recruited buy Afatinib from MSM community settings; 12 studies used multiple recruitment methods (Table 1). The sample sizes of the studies ranged from 20 to 5454 [median 402; interquartile range (IQR) 202–558]. Our trend analysis across all available studies suggested that the percentage of MSM who had ever been tested for HIV increased from ∼10.8% (95% CI −2.8–24.4%) in 2002 to ∼51.2% (95% CI 39.0–63.4%) in 2009, with an average annual growth rate of ∼5.8% per year (95% CI 2.4–9.1%) (P = 0.0013) (Fig. 1a). The percentage of Chinese MSM who reported testing for HIV in the past 12 months also increased significantly, from ∼11.0% (95% CI −4.2–26.2%) in 2003 to ∼43.7% (95% CI 37.1–50.2%) in 2009, with an average increase of approximately 4.9% per year (95% CI 1.8–8.1%) (P = 0.0034) (Fig. 1b). Four of the 55 reported that approximately 82–97% of tested MSM were also notified about their HIV status after confirmation tests [25, 33-35].

One study reported a plateau after 3 or 4 years of treatment, in

One study reported a plateau after 3 or 4 years of treatment, in all baseline CD4 cell count groups [4]. Lastly, Kelley et al. [7] reported that, after 4 years of cART, mean changes in CD4 cell count were higher in those with lower baseline CD4 cell counts. These studies included between 554 and 1638 patients maintaining Lenvatinib low viral loads – substantially fewer than the 5089 analysed here. These smaller sample sizes, together with the inevitably smaller numbers of patients followed for longer periods, may have limited their ability to distinguish long-term trends according to both baseline CD4 cell count and whether patients maintained virological suppression.

Three studies with more than 4 years of follow-up have modelled the effects of post-cART viral load (>400 copies/mL) on long-term CD4 cell counts [6,16,18]. Each reported lower post-cART CD4 cell count increases during periods of virological failure. For patients who do not maintain low viral loads throughout follow-up, after 3 or 4 years on treatment, CD4 counts start to decrease among those with higher baseline CD4 counts, and plateau for those with baseline CD4 counts of <200 cells/μL [16,18]. These studies either did not report [16,18]

or reported that they lacked the statistical power to distinguish [6] the effects of low-level compared with higher-level viraemia, or time since virological failure, on subsequent CD4 cell counts. PF-562271 mw Five studies have reported associations of factors additional to post-cART viral loads with changes in CD4 cell counts beyond 6 months of treatment [6,8,9,16,17]. Two reported higher CD4 cell count increases in younger patients but no important differences between men and women [6,16] and

one study also stated that there were no important differences by reported mode of HIV exposure [16]. The other three studies found no evidence of associations between demographic factors and increases in CD4 cell counts beyond 6 months of treatment [8,9,17]. Further Fenbendazole studies restricted to patients who maintained virological suppression reported HIV transmission via injecting drug use to be associated with lower post-cART CD4 cell counts [4] and greater increases in women than in men [25]. For the best-fitting model, we found that predicted CD4 cell counts from the model were higher than those observed. This effect was most notable among those starting treatment with low CD4 cell counts, suggesting that this was a consequence of informative censoring as a result of deaths among patients who started cART with low CD4 cell counts. Random-effects models are robust to dropout mechanisms that are predictable from observed data (‘missing at random’) [26]. Cross-sectional analyses, however, assume that dropout is independent of any observed or unobserved data (‘missing completely at random’) [26] and may produce biased estimates if this assumption is not valid.

These observations are discussed in relation to possible underlyi

These observations are discussed in relation to possible underlying functional substrates and related neurological and psychiatric pathologies. “
“The neural mechanisms generating rhythmic bursting activity in the mammalian brainstem, particularly in the pre-Bötzinger complex (pre-BötC), which is involved in respiratory rhythm generation, and in the spinal cord (e.g. locomotor rhythmic see more activity) that persist after blockade of synaptic inhibition remain poorly understood. Experimental studies

in rodent medullary slices containing the pre-BötC identified two mechanisms that could potentially contribute to the generation of rhythmic bursting: one based on the persistent Na+ current (INaP), and the other involving the voltage-gated Ca2+ current (ICa) and the Ca2+-activated nonspecific cation current (ICAN), activated by intracellular Ca2+ accumulated from extracellular Selleckchem AZD0530 and intracellular sources. However, the involvement and relative roles of these mechanisms in rhythmic bursting are still under debate. In this theoretical/modelling study, we investigated Na+-dependent and Ca2+-dependent bursting generated in single cells and heterogeneous

populations of synaptically interconnected excitatory neurons with INaP and ICa randomly distributed within populations. We analysed the possible roles of network connections, ionotropic and metabotropic synaptic mechanisms, intracellular Ca2+ release, and the Na+/K+ pump in rhythmic bursting generated under different conditions. We show that a heterogeneous population of excitatory neurons can operate in different oscillatory regimes with bursting dependent on INaP and/or ICAN, or independent of both. We demonstrate that the operating bursting mechanism may depend on neuronal excitation, synaptic interactions within the network, and the relative expression of particular ionic currents. The existence of multiple oscillatory regimes and their state dependence demonstrated in our models may explain different

rhythmic activities observed in the pre-BötC and other brainstem/spinal cord circuits under different experimental conditions. “
“Deep cerebellar nucleus (DCN) neurons show Carnitine palmitoyltransferase II pronounced post-hyperpolarization rebound burst behavior, which may contribute significantly to responses to strong inhibitory inputs from cerebellar cortical Purkinje cells. Thus, rebound behavior could importantly shape the output from the cerebellum. We used whole-cell recordings in brain slices to characterize DCN rebound properties and their dependence on hyperpolarization duration and depth. We found that DCN rebounds showed distinct fast and prolonged components, with different stimulus dependence and different underlying currents.

, 2005; Green et al, 2007; Marcos & DuPont, 2007), has come to l

, 2005; Green et al., 2007; Marcos & DuPont, 2007), has come to light. The strain carries Cyclopamine the binary toxin gene CdtB, and has an 18-base-pair deletion in the toxin repressor gene, tcdC, which means that it generates approximately 16–23 times more toxin than other strains (Warny et al., 2005). Infection is associated with a high risk of acute clinical deterioration and a poor response to metronidazole

therapy (Spigaglia & Mastrantonio, 2002; Pepin et al., 2005), making it a major concern for healthcare worldwide. Clostridium difficile ribotype 027 was initially rare in the United Kingdom; however, when outbreaks at Stoke Mandeville and the Royal Devon and Exeter Hospitals were investigated in 2004–2005, type 027 was found to predominate in their cases (Anon, 2006), MK-2206 price and this ribotype has now been detected in the majority of countries around the world (Kuijper et al., 2007). It is clear, then, that C. difficile is a significant burden on the healthcare profession and patients. With the ever-increasing availability of genomic information, however, greater insight into the evolution and variation of C.

difficile genomes is now possible (Stabler et al., 2006, 2009; He et al., 2010). The Clostridb database (http://xbase.bham.ac.uk/clostridb/) (Chaudhuri & Pallen, 2006), an excellent publicly accessible resource for those interested in comparative genomics of the genus Clostridium, currently contains genome sequences of 18 strains of clostridia, including two genomes of C. difficile, namely C. difficile 630 and C. difficile qcd32_g58, a representative of the predominant

NAP1/BI/027 strain in Quebec (Loo et al., 2005). The 4.29 Mb genome of C. difficile strain 630 and its Celastrol 7.8 kb plasmid encode a remarkable number of genes associated with resistance to antimicrobial agents, as well as virulence factors, host adherents and surface structures (Sebaihia et al., 2007). Genome sequences have been generated recently for a further six strains, including CD196, an early, nonepidemic, ribotype 027 strain (Stabler et al., 2009), the R20291 isolate responsible for the UK Stoke Mandeville outbreak, and 21 other hypervirulent ribotype 027 strains isolated over the past two decades (He et al., 2010). A further six hypervirulent isolates associated with the Quebec outbreak and a reference ATCC43255 strain are at the draft genome sequence stage (McGill University and Génome Québec Innovation Centre), while the human microbiome project at Baylor College of Medicine has draft genome sequences for two strains (NAP07, NAP08) at the time of writing. These genomic data, along with recently developed tools for Clostridial functional genomics (Heap et al., 2009), make it possible for researchers to adopt a systems approach to the dissection of the physiology and biochemistry of this pathogen.

Three female BALB/c mice were injected intraperitoneally with the

Three female BALB/c mice were injected intraperitoneally with the bacterial suspension at a volume of 0.5 mL. Twenty-four hours later, the mice were sacrificed, injected intraperitoneally with 1 mL of sterile PBS, kept for 1 min with gentle massage over the abdomen and then extracted. After serial dilution, the samples were spread KU-60019 purchase on the LB plates and incubated at 37 °C overnight.

Of the colonies recovered from the same mice, 20 were randomly picked and identified by PCR with primers O1 and O2. To calculate the competitive indices, the ratio of yncD-deleted mutant to wild type recovered from the abdominal cavity was determined and then normalized by dividing by the ratio of yncD-deleted mutant to wild type in the initial inoculum. Female BALB/c mice aged 6–8 weeks (five groups with three mice per group) were immunized once intranasally with 109 CFU of YGC102 or PBS (as control). Thirty days later, the mice of the control group were challenged with 103 CFU of wild type, whereas the mice of the other four groups were challenged respectively with 104, 105, 106 and 107 CFU of the strain using the porcine gastric mucin model as described TGF-beta inhibitor above. The survival of the mice was monitored for 7 days. A promoterless egfp gene from pEGFP-N2 was isolated by digestion with EcoRI and HindIII

and was subcloned into the corresponding sites of the pBR322 plasmid, resulting in the pBGPL plasmid. The yncD promoter region was amplified by PCR using the primers EPR1 and EPR2 (Table 1). The promoter fragment was ligated directly with PMD18-T vector and subcloned as NcoI fragments into the corresponding sites of pBGPL resulting in the pBGP plasmid. The generated plasmid was electroporated into the YGC101 strain to generate YGC104 strain. The YGC104 strain cells were inoculated into the indicated media (for the heat-shock experiment, cells were incubated at

45 °C for 10 min) and grown at 37 °C for 5 h to allow expression of enhanced green fluorescent protein (EGFP). Then, the bacteria were diluted with PBS and analyzed in a flow Metalloexopeptidase cytometer (BD FACSCanto II) with the gates set to forward and side scatters characteristic of the bacteria. The optical detector FL1-H was used for this measurement. For each condition assessed, 10 000 bacterial cells were analyzed and the mean fluorescent intensity of the bacteria was obtained. Each experiment was performed in triplicate. Comparisons of expression values among the groups were performed by t-test. Total RNA was isolated from bacterial cells of Ty2 wild type incubated under each condition using the SV Total RNA Isolation System (Promega). Additional treatments with RNase-Free DNase I (Takara) were performed to eliminate any genomic DNA. The quantity and quality of the total RNA was determined with an ND-1000 spectrophotometer (NanoDrop). The cDNAs were synthesized using the PrimeScript RT reagent kit (Takara).

However, this difference was not statistically significant (P = 0

However, this difference was not statistically significant (P = 0.15). Pulmonary mRNA expression of cytokines Anti-infection Compound Library concentration and immune molecules in the lungs of the test mice was also analysed (Fig. 3). After 4 weeks, pulmonary mRNA expression

of IL-2 and IFN-ar1 was significantly higher in the test mice than in the control mice (P < 0.01). Pulmonary mRNA expression of IL-12a and IL-12rb1 tended to be higher in the test mice than in the control mice. However, such changes were not statistically significant (P = 0.074 and 0.068, respectively). TMC0356 is a new probiotic strain of L. gasseri that was originally isolated from the intestine of a healthy human adult (Hosoda et al., 1998). This bacterium has expressed strain-dependent immune regulatory effects such as apparent simulation

of IL-12 production from macrophages in cell line and animal studies (Morita et al., 2002; Harata et al., 2009; Kawase et al., 2009). In several recent animal and human studies, TMC0356 significantly improved allergic symptoms in patients with Japanese cedar pollinosis and in ovalbumin-immunized animals, protected host animals from influenza virus infection, and significantly suppressed the growth Crenolanib chemical structure of translated tumors (Kawase et al., 2006, 2007a, b, 2009; Harata et al., 2009; Wang et al., 2009). These health-promoting effects of TMC0356 are believed to be partly a result of a strain-dependent regulatory effect on cell-mediated immunity (CMI) of host animals characterized by elevated IFN-γ production and increased Th1-type immunity. Recently, some selected Lactobacillus and Bifidobacterium strains with properties that bolster CMI have been found to possess potent health-promoting effects against various age-associated physiological changes such as the development of osteoporosis (Kimoto-Nira et al., 2007, 2009). In light of these findings, FER we hypothesized that TMC0356 might positively alter the immunosenescence of aged host animals by stimulating their CMI, and consequently might improve the

natural defense of aged host animals against various infections. SAM is a well-known murine model of accelerated senescence. SAM consists of SAMP (prone) and SAMR (resistant) lines. SAMP lines are characterized by the accumulation of senile features as well as earlier onset and faster progress of age-related pathological phenotypes, such as amyloidosis, impaired immune responses, senile osteoporosis, and deficits in learning and memory (Hanada et al., 1991). Furthermore, age-related early loss of immune function has been clearly demonstrated in SAMP strains such as profound defects in the antibody response to a TD antigen, early onset of regression and a sharp decline in NK cell activity from the level in the control mice at 2 months of age (Hosokawa et al., 1987a, b). In the present study, splenic activation of NK cells of the control SAMP1 mice decreased with age from 20 to 24 weeks (between 4 and 8 weeks of oral administration of saline).

Further evaluation should follow as for that set out in Box 1 Fa

Further evaluation should follow as for that set out in Box 1. Failure this website is defined as ‘failure to achieve a VL <50 copies/mL 6 months after commencing ART or following viral suppression to <50 copies/mL a VL rebound to >400 copies/mL on two consecutive occasions’. In the UK, approximately 18% of those achieving an undetectable VL in 2008–2009 experienced

VL rebound. In the same database, among drug-experienced patients the overall prevalence of resistance was 44% in 2007 [1]]. Confirmation of virological failure at any stage should lead to the practice set out in Box 1. We recommend patients experiencing virological failure on first-line ART with WT virus at baseline and without emergent resistance mutations at failure switch to a PI/r-based combination ART regimen (1C). We recommend patients experiencing virological failure on first-line ART with WT virus at baseline and limited emergent resistance mutations (including two-class NRTI/NNRTI) at failure switch to a new PI/r-based regimen with the addition of at least one, preferably two, active drugs (1C). We recommend patients experiencing virological failure on first-line PI/r plus two-NRTI-based regimens, with major protease mutations, switch to a new active PI/r with the addition of at least one, preferably two, active agents of which one has a novel mechanism of action (1C). GSK126 chemical structure We recommend against switching a PI/r to an

INI or NNRTI as the third agent in patients with historical or existing RT mutations associated with NRTI resistance or past virological failure on NRTIs

(1B). A significant minority of patients have WT virus despite failing on therapy [24-30]. Failure here is usually attributable to poor treatment adherence with drug levels that are both insufficient to maintain VL suppression and inadequate to select out viral mutations associated with drug resistance detectable on standard tests. Factors affecting adherence such as tolerability/toxicity issues, regimen convenience, Buspirone HCl drug–food interactions and mental health/drug dependency problems should be fully evaluated and where possible corrected before initiation of the new regimen. Additional adherence support should be considered and careful discussion with the patient take place. TDM may be of benefit in individual patients in confirming low/absent therapeutic drug levels and enabling discussion with the patient. A priority question the Writing Group addressed was whether patients failing an NNRTI-based ART without detectable resistance should receive a PI/r-based regimen. The absence of detectable resistance mutations does not exclude the presence of mutations in minor virus populations, especially with the NNRTIs [9-11]. This may lead to subsequent failure if the same first-line drugs, or drugs in the same class, are prescribed [31, 32]. Testing for minority resistance is a specialist test and expert interpretation by a virologist is essential.

, 2009) In this work, we show that

, 2009). In this work, we show that selleck inhibitor the use of functional genes, as the bacterial LmPH gene, as a proxy to study microbial diversity of relevant microorganisms in leaf litter decomposition is possible. We are confident that the use of other functional genetic markers

of bacteria, and its extension to the study of fungi, will provide additional and interesting results to support the idea of changing microbial communities in the process of litter decomposition and increase our understanding of how microorganism interacts in ecosystem processes. The authors acknowledge the contribution of Anna Díez to laboratory work. This research was financially supported by the Spanish Government through projects CGL2009-08338 and CGL2011-30151-C02-01. “
“hrp genes encode components of a type III secretion (T3S) system and play crucial roles in the pathogenicity of the rice pathogen Xanthomonas oryzae pv. oryzae (Xoo).

A histone-like nucleoid-structuring (H-NS) protein binds DNA and acts as a global Roxadustat manufacturer transcriptional repressor. Here, we investigated the involvement of an h-ns-like gene, named xrvB, in the expression of hrp genes in Xoo. Under the hrp-inducing culture condition, the expression of a key hrp regulator HrpG increased in the XrvB mutant, followed by activation of the downstream gene expression. Also, in planta, the secretion of a T3S protein (XopR) was activated

by the mutation in xrvB. Gel retardation assay indicated that XrvB has DNA-binding activity, but without a preference for the promoter region of hrpG. The results suggest that XrvB negatively regulates hrp gene expression and that an unknown factor(s) mediates the regulation of hrpG expression by XrvB. Xanthomonas oryzae pv. oryzae (Xoo) is the causal agent of bacterial leaf blight of rice (Swings et al., 1990; Niño-Liu et al., 2006). Like other Gram-negative phytopathogenic bacteria in the genera Erwinia, Pseudomonas, Ralstonia and Xanthomonas, Xoo possesses hypersensitive response and pathogenicity (hrp) genes, which play critical roles in conferring pathogenicity on host plants and triggering a hypersensitive response in nonhost plants (Alfano & Collmer, 1997). The hrp genes are involved in the construction Adenosine of a type III secretion (T3S) apparatus, through which bacterial virulence-associated proteins (effectors) are directly delivered into plant cells (Büttner & Bonas, 2002). The expression of hrp genes is tightly regulated and is induced in planta, but suppressed in complex media. Appropriate hrp-inducing media have been established for several bacteria; the media are generally nutrient poor and likely to mimic plant conditions (Schulte & Bonas, 1992; Xiao et al., 1992; Wengelnik et al., 1996a; Brito et al., 1999; Tsuge et al., 2002).

, 2008; De Baets et al, 2009) FAFLP is a high-resolution and re

, 2008; De Baets et al., 2009). FAFLP is a high-resolution and reproducible

methodology that assesses the genome for genetic polymorphism between strains of the same and different species. The method identifies polymorphisms resulting in point mutations within the restriction-site targeted by the endonucleases used for the analysis. This may result in either loss or gain of fragments, or insertion or deletion between the two endonuclease restriction-priming sites, thus resulting in polymorphic fragments of varying sizes. A strain-characteristic FAFLP profile varying in the number and sizes of the fragments is obtained. A recent paper by Desai et al. (2006) examined the genetic stability of bacterial strains preserved by two different methods, lenticulation and freeze-drying, using PD-166866 in vitro FAFLP. No detectable genetic changes were found between the two approaches to preservation, or as a result of storage of isolates over a 5-year period. However, to our knowledge, there have been no studies evaluating the potential introduction of random mutations

or chromosomal rearrangements as a result of repeated subcultures of the reference cultures used in food microbiology laboratories. In Fluorouracil datasheet this study, we examined the genetic stability of the working cultures (control strains will henceforth be referred to as working cultures) obtained from different food laboratories using standardized FAFLP analysis. The resultant FAFLP profiles were compared with those obtained from the relevant reference NCTC strains, which were freeze-dried in evacuated glass ampoules or preserved on LENTICULE discs. Eight food examination

laboratories accredited by the United Kingdom Accreditation Service (UKAS) for a wide range of food examination procedures agreed to participate in this study. Each laboratory was anonymized and designated a number Benzatropine (Lab #1 to Lab #8; Table 1). All the laboratories had purchased the control strains for their reference stocks from NCTC as freeze-dried cultures in glass ampoules. Each laboratory submitted their working culture that had been prepared from their reference stock. Working cultures of four different bacterial species were submitted by each of the eight laboratories. Corresponding ampoules containing freeze-dried cultures of the four strains were obtained directly from NCTC to be used as reference strains for the study. The bacterial cultures included Salmonella Nottingham (NCTC 7832), Listeria monocytogenes (NCTC 11994), Staphylococcus aureus (NCTC 6571) and Bacillus cereus (NCTC 7464) (Table 1), and a total of 50 isolates were examined in this study. Individual laboratories submitted isolates from their current working culture by inoculating nutrient agar slopes and incubating the slopes overnight at 37 °C. The slopes were sent to Microbiology Services Colindale at the Health Protection Agency (HPA) for examination.

Although the expression levels of the eight genes were 017–063-

Although the expression levels of the eight genes were 0.17–0.63-fold in the ΔsdrP strain relative to that in wild type, their q-values except that of TTHA1128 were 0.061–0.242, which were greater than the threshold value used in the experiment (0.06). As for TTHA1128, identification of a SdrP-binding site in the promoter region was missed in the previous study. Conversely, expression of four out of 14 SdrP-regulated genes identified in the previous study showed lower correlation to that of sdrP (Spearman’s correlation

coefficients≤0.51). Some unknown factors such as promoter activity and affinity of SdrP to DNA in vivo, and unidentified transcriptional regulator(s) that might act together with SdrP, might influence the results of the experimental screenings for SdrP-regulated click here genes. Thus, a combination of comparative expression analysis and expression pattern analysis was appropriate for screening of SdrP-regulated genes. Among the environmental and chemical stresses examined in this study, the diamide and H2O2 stresses were the

most effective in enhancing the expression of sdrP and its target genes in the wild-type strain. Furthermore, an excess amount of CuSO4 was Ruxolitinib nmr a strong inducer of sdrP gene expression in the ΔcsoR strain, in which excess Cu(I) ions may accumulate (Sakamoto et al., 2010). In this strain, excess Cu(I) ions, which have the potential to drive oxidation/reduction to form free radicals (Touati, 2000; Imlay, 2002), may trigger expression of sdrP. As for the possible cellular functions of the 22 SdrP-regulated gene products, at least nine, i.e. TTHA0425, TTHA0557, TTHA0654, TTHA0986, TTHA1028, TTHA1215, TTHA1625, TTHA1635, and TTHB132, are possibly involved in redox control (Table 2) (Agari et al., 2008). UvrB (TTHA1892) Teicoplanin may be involved in the repair of oxidized DNA. The altered expression levels of sdrP and its target genes in the stationary growth phase were similar to those caused by diamide treatment. These

results suggest that the main inducer of sdrP expression is oxidative stress, and support the previous finding that SdrP functions in the response to oxidative stress. Because SdrP does not have a cysteine residue or cofactor that could be a sensor of an oxidative signal [unlike in the case of other oxidative stress-responsive transcriptional regulators such as OxyR, PerR, and SoxR (Storz & Imlay, 1999; Pomposiello & Demple, 2001; Lee & Helmann, 2006)], and it does not require any effector molecule for its transcriptional activation (Agari et al., 2008), there may be some unidentified factor(s) sensing oxidative stress and causing induced expression of SdrP. It has been demonstrated that the bacterial response to a specific stress can increase the resistance to other stresses, probably because stresses are not encountered in isolation in nature (Tesone et al., 1981; Jenkins et al., 1988; Jenkins et al., 1990; Hengge-Aronis et al., 1993; Storz & Imlay, 1999; Canovas et al.